In a new study, Stanford researchers studied estimates and benchmark times for common surgeries to evaluate the work of the committee that decides how much a physician should be reimbursed from Medicare for their services.
In a new study, the researchers found an unintended consequence of the public disclosure system: It may have diminished trust in even those physicians who never received payments from drug or medical device firms.
A new Stanford center brings together multidisciplinary researchers and advanced technologies to shepherd drug development from preliminary research through preclinical and clinical trials.
California will need to change all sectors of its economy extensively to reach its ambitious climate goals, but the right portfolio of technologies can help the state meet them, at least in the near term.
In preclinical trials, Stanford scientists and their collaborators harnessed the gene-editing system CRISPR-Cas9 to replace the mutated gene underpinning the devastating immune disease.
A large study of women with breast and ovarian cancer has revealed significant gaps between national guidelines for genetic testing and actual testing practices, according to researchers from Stanford and five other institutions.
